Eplerenone for chronic central serous chorioretinopathy-a randomized controlled prospective study.
Roy SchwartzZohar Habot-WilnerMichael R MartinezAmir NutmanDafna GoldenbergShai CohenShiri ShulmanHanan Guzner-GurAnat LoewensteinMichaella GoldsteinPublished in: Acta ophthalmologica (2017)
In this study, eplerenone was not found to be superior to placebo in eyes with chronic CSC.